Neuren Pharmaceuticals Limited
NURPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $142 | $157 | $0 | -$8 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | -$3 | -$1 | -$3 |
| Stock-Based Comp. | $0 | $0 | $2 | $1 |
| Change in WC | -$158 | $23 | $1 | -$3 |
| Other Non-Cash | $4 | $8 | $2 | $3 |
| Operating Cash Flow | -$11 | $185 | $4 | -$10 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$211 | $0 | $0 |
| Inv. Sales/Matur. | $4 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $4 | -$211 | -$0 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $2 | $4 | $0 | $23 |
| Stock Repurch. | -$10 | $0 | -$0 | -$1 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | -$0 | $0 |
| Financing Cash Flow | -$9 | $4 | -$0 | $22 |
| Forex Effect | $2 | -$0 | -$0 | $0 |
| Net Chg. in Cash | -$14 | -$23 | $3 | $13 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $17 | $40 | $37 | $24 |
| End Cash | $3 | $17 | $40 | $37 |
| Free Cash Flow | -$11 | $185 | $4 | -$10 |